Financial reports
10-Q
2023 Q2
Quarterly report
18 Oct 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
29 Mar 22
Current reports
8-K
Entry into a Material Definitive Agreement
31 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Jul 23
8-K
Departure of Directors or Certain Officers
7 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1 Jun 23
8-K
Entry into a Material Definitive Agreement
3 Feb 23
8-K
Departure of Directors or Certain Officers
20 Jan 23
8-K
Termination of a Material Definitive Agreement
9 Jan 23
8-K
Other Events
28 Nov 22
8-K
Nabriva Therapeutics Pivoting Strategic Focus
10 Nov 22
8-K
Other Events
4 Oct 22
Registration and prospectus
15-12G
Securities registration termination
25 Oct 23
POS AM
Prospectus update (post-effective amendment)
19 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Oct 23
Proxies
DEF 14A
Definitive proxy
11 Jul 22
PRE 14A
Preliminary proxy
29 Jun 22
DEFA14A
Additional proxy soliciting materials
22 Feb 22
DEFA14A
Additional proxy soliciting materials
18 Jan 22
DEFA14A
Additional proxy soliciting materials
14 Jan 22
DEFA14A
Additional proxy soliciting materials
14 Jan 22
DEFA14A
Additional proxy soliciting materials
7 Jan 22
DEFA14A
Additional proxy soliciting materials
28 Dec 21
DEFA14A
Additional proxy soliciting materials
22 Dec 21
DEF 14A
Definitive proxy
22 Nov 21
Other
EFFECT
Notice of effectiveness
25 Oct 23
CT ORDER
Confidential treatment order
18 Jul 22
EFFECT
Notice of effectiveness
2 Nov 21
CORRESP
Correspondence with SEC
28 Oct 21
CT ORDER
Confidential treatment order
19 Oct 21
UPLOAD
Letter from SEC
15 Oct 21
CT ORDER
Confidential treatment order
7 Apr 21
EFFECT
Notice of effectiveness
14 Sep 20
CORRESP
Correspondence with SEC
9 Sep 20
UPLOAD
Letter from SEC
8 Sep 20
Ownership
3
H MICHAEL HOGAN III
10 Jul 23
3
David Maggio
10 Jul 23
4
Steven P. Gelone
31 Jan 23
4
Theodore R Schroeder
31 Jan 23
4
Steven P. Gelone
10 Jan 23
4
Theodore R Schroeder
10 Jan 23
4
Theodore R Schroeder
4 Jan 23
4
Steven P. Gelone
4 Jan 23
4
Steven P. Gelone
8 Dec 22
4
Theodore R Schroeder
8 Dec 22